Diminishing diagnosis of follicular thyroid carcinoma

Otto, Kristen J.; Lam, Jacqueline; MacMillan, Christina; Freeman, Jeremy L.

doi:10.1002/hed.21373

Cited by 20 publications

(14 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…, 20 using as a threshold the size of 1 cm for primary tumour diameter, found an exponentially increased risk of more advanced disease with greater size for both PTC and FTC. Our data corroborate results of previous studies (although not all) showing the dramatic reduction in the frequency of FTC and the subsequently increased proportion of PTC 13,21 . In group I, FTC represented 25% of the DCT, but in group IV only 6·5% were FTC.…”

Section: Discussionsupporting

confidence: 92%

Changes in TNM stage, reoperation and 131‐I ablation rate during the use of newer methods for the preoperative diagnosis of differentiated thyroid carcinoma

Karga

Mavroudis

Giagourta

et al. 2012

Clinical Endocrinology

View full text Add to dashboard Cite

show abstract

Section: Discussionsupporting

confidence: 92%

Changes in TNM stage, reoperation and 131‐I ablation rate during the use of newer methods for the preoperative diagnosis of differentiated thyroid carcinoma

Karga

Mavroudis

Giagourta

et al. 2012

Clinical Endocrinology

View full text Add to dashboard Cite

show abstract

“…The reporting rate of NIFTP on histopathology is quite variable in the published data, which may be caused by multiple factors, including patient demographics, referral patterns, and the diagnostic threshold of individual cytopathologists and surgical pathologists. Currently, FVPTC represents a significant proportion (approximately 15%‐20%) of PTC diagnoses with increasing incidence . With the nomenclature change from NI‐FVPTC to NIFTP, a significant fraction of these PTCs will be excluded from classification as malignant .…”

Section: Discussionmentioning

confidence: 99%

Noninvasive follicular thyroid neoplasm with papillary‐like nuclear features (NIFTP): Implications for the risk of malignancy (ROM) in the Bethesda System for Reporting Thyroid Cytopathology (TBSRTC)

Zhou

Baloch

Nayar

et al. 2017

Cancer Cytopathology

View full text Add to dashboard Cite

The institutional frequency of NIFTP histopathology diagnosis and cytology baseline data will impact the ROM associated with specific FNAC diagnoses, especially among the indeterminate TBSRTC categories. The range of ROM for each TBSRTC diagnostic category is reflective of the inherent diagnostic thresholds and interobserver and interinstitutional variability in the diagnosis of thyroid lesions. Cancer Cytopathol 2018;126:20-6. © 2017 American Cancer Society.

show abstract

“…FTC currently represents 10% or less of thyroid cancer cases diagnosed in children or young adults (8,50,(358)(359)(360), and the prevalence of true FTC appears to be decreasing over time (361). FTC is most commonly diagnosed in adolescents, and there is less of a female to male preponderance compared with PTC (9,11,50,51,226).…”

Section: Recommendation Rating: C [E1] Follicular Thyroid Cancermentioning

confidence: 99%

Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer

Francis

Waguespack

Bauer

et al. 2015

Thyroid

1,017

1,365

View full text Add to dashboard Cite

Background: Previous guidelines for the management of thyroid nodules and cancers were geared toward adults. Compared with thyroid neoplasms in adults, however, those in the pediatric population exhibit differences in pathophysiology, clinical presentation, and long-term outcomes. Furthermore, therapy that may be recommended for an adult may not be appropriate for a child who is at low risk for death but at higher risk for long-term harm from overly aggressive treatment. For these reasons, unique guidelines for children and adolescents with thyroid tumors are needed. Methods: A task force commissioned by the American Thyroid Association (ATA) developed a series of clinically relevant questions pertaining to the management of children with thyroid nodules and differentiated thyroid cancer (DTC). Using an extensive literature search, primarily focused on studies that included subjects £ 18 years of age, the task force identified and reviewed relevant articles through April 2014. Recommendations were made based upon scientific evidence and expert opinion and were graded using a modified schema from the United States Preventive Services Task Force. Results: These inaugural guidelines provide recommendations for the evaluation and management of thyroid nodules in children and adolescents, including the role and interpretation of ultrasound, fine-needle aspiration cytology, and the management of benign nodules. Recommendations for the evaluation, treatment, and follow-up of children and adolescents with DTC are outlined and include preoperative staging, surgical management, postoperative staging, the role of radioactive iodine therapy, and goals for thyrotropin suppression. Management algorithms are proposed and separate recommendations for papillary and follicular thyroid cancers are provided.

show abstract

Diminishing diagnosis of follicular thyroid carcinoma

Cited by 20 publications

References 13 publications

Changes in TNM stage, reoperation and 131‐I ablation rate during the use of newer methods for the preoperative diagnosis of differentiated thyroid carcinoma

Changes in TNM stage, reoperation and 131‐I ablation rate during the use of newer methods for the preoperative diagnosis of differentiated thyroid carcinoma

Noninvasive follicular thyroid neoplasm with papillary‐like nuclear features (NIFTP): Implications for the risk of malignancy (ROM) in the Bethesda System for Reporting Thyroid Cytopathology (TBSRTC)

Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer

Contact Info

Product

Resources

About